✦ LIBER ✦

The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients

✍ Scribed by De Backer, W.; Vos, W.; Van Holsbeke, C.; Vinchurkar, S.; Claes, R.; Hufkens, A.; Parizel, P. M.; Bedert, L.; De Backer, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of long-acting bronchodilators i

✍ Decramer, Marc; Dahl, Ronald; Kornmann, Oliver; Korn, Stephanie; Lawrence, David 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 428 KB

PRS34 Cost-Effectiveness of Roflumilast

✍ Lindner, L.; Camins de Valdenebro, L.; Aparicio Martinez, J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PRS3 COST-EFFECTIVENESS OF ROFLUMILAST I

✍ F Van Nooten; M Rutten-van Molken; M Lindemann; R Sandtmann 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Additive effects of transdermal tulobute

✍ Masakazu Ichinose; Kuniaki Seyama; Masaharu Nishimura; Yoshinosuke Fukuchi; Atsu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Cost-effectiveness of roflumilast as an

✍ Samyshkin, Yevgeniy; Kotchie, Robert W.; Mörk, Ann-Christin; Briggs, Andrew H.; 📂 Article 📅 2013 🏛 Springer 🌐 French ⚖ 377 KB

Effect of an additional dose of indacate

✍ Mario Cazzola; Andrea Segreti; Emanuele Stirpe; Ermanno Puxeddu; Josuel Ora; Pao 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 386 KB